Targeted cancer therapy is based on exploiting selective dependencies of tumor cells. By 35 leveraging recent large-scale genomic profiling and functional screening of cancer cell lines we 36 identified Werner syndrome helicase (WRN) as a novel specific vulnerability of microsatellite 37 instability-high (MSI-H) cancer cells. MSI, caused by defective mismatch repair is frequently 38 detected in human malignancies, in particular in colorectal, endometrial and gastric cancers. We 39 demonstrate that WRN inactivation selectively impairs the viability of MSI-H but not microsatellite 40 stable (MSS) colorectal and endometrial cancer cell lines. In MSI-H cells, WRN loss results in 41
Introduction 47
Defects in components of the DNA repair machinery, such as BRCA1/2 mutations or impaired 48 DNA mismatch repair (MMR), are a common characteristic of tumor cells, accelerating the 49 accumulation of DNA mutations or chromosomal aberrations that are required for neoplastic 50 transformation (Kinzler and Vogelstein 1997) . Plasticity of genome stability pathways permits 51 tumor cells to tolerate the loss of individual DNA repair genes and leads to synthetic lethality (SL) 52 upon targeting the compensating repair mechanism (Nickoloff, Jones et al. 2017 ). The first 53 clinically approved drugs exploiting such a SL interaction are Poly(ADP-Ribose) Polymerase 54 (PARP) inhibitors for therapy of BRCA1/BRCA2-deficient tumors (Kaufman, Shapira-Frommer et 55 al. 2015, Lord and Ashworth 2017) . 56 MMR deficiency is caused by inactivation of genes of the DNA repair machinery involved in the 57 resolution of nucleotide base-base mismatches during DNA replication (Jiricny 2006) . MMR 58 defects lead to characteristic variations in the length of tandem nucleotide repeats across the 59 genome, known as microsatellite instability (MSI) (Aaltonen, Peltomaki et al. 1993, Ionov, 60 1996, Kitao, Shimamoto et al. 1999 , Siitonen, Kopra et al. 2003 , Van Maldergem, Siitonen et al. 80 2006) . Specifically, patients with Werner syndrome display a premature ageing phenotype 81 including arteriosclerosis, type II diabetes and osteoporosis and are prone to develop tumors of 82 mesenchymal origin, such as soft tissue sarcoma or osteosarcoma (Hickson 2003, Goto, 83 Ishikawa et al. 2013). WRN is unique among RecQ family helicases in possessing 3'-5' 84 exonuclease activity (Huang, Li et al. 1998 , Kamath-Loeb, Shen et al. 1998 , Shen, Gray et al. 85 1998 In contrast to the previously described tumor-suppressive role of WRN, we demonstrate in this 87 study that WRN possesses a context-dependent critical pro-survival function for cancer cells. Next, we wanted to experimentally validate the MSI status in a select set of cell lines. To this end, 115
we used a fluorescent PCR-based analysis of five mononucleotide microsatellite markers to 116 determine the MSS/MSI-H status of a subset of CRC, gastric and endometrial cancer cell 117 models (Table 1 ). In addition, we utilized a comprehensive MSS/MSI-H status annotation of 118 CRC cell models reported by Medico and colleagues (Medico, Russo et al. 2015) . Analysis of 119 gene dependency and MSS/MSI-H status data revealed that WRN dependency was strongly 120 associated with MSI-H status across CRC, gastric and endometrial models (p=6.11*10 -8 ). Of the 121
WRN depletion by siRNA selectively impairs viability of MSI-H CRC and endometrial 126 cancer cell lines 127
To experimentally corroborate the WRN dependency of MSI-H cancer cells, we applied short-128 interfering RNA (siRNA)-mediated knock-down of WRN in a panel of three MSS (SK-CO-1, 129
CaCo-2, SW480) and three MSI-H (HCT 116, RKO, SNU-C4) CRC cell lines. In agreement with 130 the results from Project DRIVE, WRN depletion using a mixture of four siRNA duplexes (Pool) or 131 an individual siRNA (#1) targeting WRN profoundly affected viability in MSI-H, but not in MSS 132 CRC models (Figure 2A ). In contrast, depletion of the known essential mitotic kinase, PLK1, had 133 a detrimental effect on viability of both MSS and MSI-H cell lines. Efficient depletion of WRN 134 protein following siRNA transfection was confirmed by immunoblotting ( Figure 2A ). The selective 135 dependency on WRN was mirrored in colony formation assays with two MSS (LS1034, SK-CO-1) 136 and two MSI-H cell lines (HCT 116, RKO) ( Figure 2B ). Likewise, we observed that WRN knock-137 down impaired viability of three MSI-H endometrial carcinoma cells lines (HEC-265, ISHIKAWA, 138 HEC-6), but not the MSS cell line MFE-280 ( Figure 2C 
CRISPR/Cas9-mediated knock-out of WRN confirms the selective dependency of MSI-H 154

CRC models on WRN 155
We carried out CRISPR-Cas9 depletion assays in MSS and MSI-H CRC models to 156 independently confirm the selective WRN dependencies observed in shRNA/siRNA studies. Cell 157 lines were stably transduced with Cas9 followed by transduction of lentiviral particles co-158 expressing GFP and single guide RNAs (sgRNAs) targeting WRN or the essential replication 159 factor RPA3 ( Figure 3A ). To investigate the relevance of the different protein domains in WRN 160 by CRISPR scanning (Shi, Wang et al. 2015 Figure 4A ). Wild-type and mutant forms of WRNr were 181 transduced in HCT 116 cells and monoclonal lines with matched stable WRNr expression were 182 generated. Expression and nuclear accumulation of transgenic WRNr variants among the cell 183 lines was confirmed using immunofluorescence analysis ( Figure 4B ). Immunoblotting revealed 184 that transgenic WRNr wild-type as well as the mutant WRN proteins were expressed at levels 185 higher than the endogenous WRN counterpart ( Figure 4B ). Two wild-type WRNr expressing 186 clones were selected based on the respective high and low expression of the transgene in order 187 to cover the range of mutant WRNr variant expression observed in the selected panel of clones. 188
As expected, viability of empty vector control-transduced cells was strongly reduced upon 189 depletion of WRN ( Figure 4C ). Importantly, both the high and low expression level of wild-type 190
WRNr was sufficient to render HCT 116 cells inert to knock-down of endogenous WRN ( immunotherapy agents for the benefit of MSI-H cancer patients. 305
Materials and Methods 306
Random Forrest model 307
To explore the hypothesis that WRN sensitivity is associated with MSI, we employed an 308 exploratory machine learning approach (Qi 2012 were transduced with vectors encoding GFP and sgRNAs targeting different domains of WRN 394 (Table 3) SLC23A1_st  BLM  WISP3  MSH6  OGT  EXO1  SLC23A1  APAF1  AXIN2_st  CHEK1  HMMR  TCF4  GRB14  AXIN2  CASP5  MLH3  IGF2R  PTEN  BAX  BCL10  RAD50  FAS  MSH2  MSH3  ACVR2A  SEC63  PRDM2  MBD4  TGFBR2 
